Ferroptosis: Potential opportunities for natural products in cancer therapy DOI

Anzheng Nie,

Chaozan Shen,

Zheng Zhou

и другие.

Phytotherapy Research, Год журнала: 2023, Номер 38(3), С. 1173 - 1190

Опубликована: Дек. 20, 2023

Abstract Cancer cells often exhibit defects in the execution of cell death, resulting poor clinical outcomes for patients with many cancer types. Ferroptosis is a newly discovered form programmed death characterized by intracellular iron overload and lipid peroxidation membrane. Increasing evidence suggests that ferroptosis closely associated wide variety physiological pathological processes, particularly cancer. Notably, various bioactive natural products have been shown to induce initiation cells, thereby exerting anticancer effects. In this review, we summarize core regulatory mechanisms multifaceted roles Importantly, focus on regulate such as terpenoids, polyphenols, alkaloids, steroids, quinones, polysaccharides. The efficacy, adverse effects, drug–drug interactions these need be evaluated further high‐quality studies accelerate their application treatment.

Язык: Английский

MYC in liver cancer: mechanisms and targeted therapy opportunities DOI
Furong Liu, Zhibin Liao, Zhanguo Zhang

и другие.

Oncogene, Год журнала: 2023, Номер 42(45), С. 3303 - 3318

Опубликована: Окт. 13, 2023

Язык: Английский

Процитировано

15

New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma DOI

Feimu Fan,

Joshua S. Fleishman, Chen Jin

и другие.

Drug Discovery Today, Год журнала: 2024, Номер 29(8), С. 104069 - 104069

Опубликована: Авг. 1, 2024

Язык: Английский

Процитировано

5

Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives DOI Creative Commons
Yuhang Chen,

Shengyuan Dai,

Chien‐shan Cheng

и другие.

Journal of Hematology & Oncology, Год журнала: 2024, Номер 17(1)

Опубликована: Дек. 21, 2024

Lenvatinib is a multi-target tyrosine kinase inhibitor widely used in the treatment of hepatocellular carcinoma (HCC). Its primary mechanism action involves inhibiting signal pathways such as vascular endothelial growth factor receptors (VEGFR) and fibroblast (FGFR), thereby reducing tumor cell proliferation angiogenesis affecting tumor's immune microenvironment. In liver cancer, although lenvatinib monotherapy has shown good clinical effect, problem drug resistance becoming more serious. This may be caused by variety factors, including genetic mutations, signaling pathway remodeling, changes order to overcome resistance, combination other therapeutic strategies gradually become research hotspot, it worth noting that checkpoint inhibitors (ICIs) application prospect. not only enhances anti-tumor response but also helps improve efficacy. However, therapy faces challenges regarding safety tolerability. Therefore, studying mechanisms identifying relevant biomarkers particularly important, aids early diagnosis personalized treatment. article reviews treating efficacy its with inhibitors, causes exploration biomarkers, novel for lenvatinib. We hope provide insights into use scientific settings, offering new cancer.

Язык: Английский

Процитировано

5

APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway DOI

Shuangqiu Du,

Jingtong Wang,

Miaomiao Liu

и другие.

Biochemical Genetics, Год журнала: 2025, Номер unknown

Опубликована: Янв. 4, 2025

Язык: Английский

Процитировано

0

Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies DOI
Xue Jiang,

Xiaoying Ge,

Yueying Huang

и другие.

Cancer Letters, Год журнала: 2025, Номер unknown, С. 217472 - 217472

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

TREM2 promotes the formation of a tumor-supportive microenvironment in hepatocellular carcinoma DOI Creative Commons

Hanrui Guo,

Meiling Wang, Cai‐Fang Ni

и другие.

Journal of Experimental & Clinical Cancer Research, Год журнала: 2025, Номер 44(1)

Опубликована: Янв. 21, 2025

Abstract Background Triggering receptor expressed on myeloid cells 2 (TREM2), a surface predominantly cells, is major hub gene in pathology-induced immune signaling. However, its function hepatocellular carcinoma (HCC) remains controversial. This study aimed to evaluate the role of TREM2 tumor microenvironment context HCC progression. Methods was experimentally induced wild-type (WT) and Trem2 -deficient ( −/− ) mice, clinical sample analysis vitro studies macrophages were conducted. treated with conditioned medium from WT or macrophages, their malignant phenotypes underlying mechanisms analyzed. Results deficiency reduced liver burden orthotopic subcutaneous models by altering CD8 + T cell infiltration. presented increased chemokine secretion. TGF-β1 found be positively correlated expression HCC, TGF-β blockade reversed induction. On other hand, associated glycolysis PKM2 cells; this association may related secretion IL-1β, which enhances cells. Conclusions These results reveal that play driving progression suppressing infiltration promoting glycolysis, providing new therapeutic target for HCC.

Язык: Английский

Процитировано

0

Rational design of peptides to overcome drug resistance by metabolic regulation DOI
Min Sun, Le He, Ran Chen

и другие.

Drug Resistance Updates, Год журнала: 2025, Номер unknown, С. 101208 - 101208

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis DOI Creative Commons
Qian Yin,

Yu Yao,

Jiaojiao Ni

и другие.

Molecular Medicine, Год журнала: 2025, Номер 31(1)

Опубликована: Фев. 20, 2025

Metabolic reprogramming is a hallmark of hepatocellular carcinoma (HCC) progression, driving aberrant cellular processes in response to pathological stimuli. While dihydrolipoyl transacetylase (DLAT) has been implicated the development various cancers, its specific role and underlying mechanisms HCC remain unclear. This study aimed investigate expression, function, mechanistic impact DLAT HCC. A comprehensive analysis was conducted using RNA sequencing data, tissue microarrays, vitro vivo functional assays, studies evaluate tumor associated molecular pathways Our revealed significant upregulation expression HCC, which linked poor prognosis. Furthermore, we discovered that facilitated metastasis by metabolic cells. Mechanistically, found enhance glucose transporter 1 (GLUT1) via H3K18 acetylation, thereby promoting aerobic glycolysis epithelial-to-mesenchymal transition (EMT), subsequently augmented both vivo. Finally, confirmed positive correlation between GLUT1 tissues. These findings establish as key regulator progression suggest potential promising predictive biomarker therapeutic target for improving diagnosis treatment.

Язык: Английский

Процитировано

0

Glycolysis-related gene signatures and the functional role of P4HA1 in osteosarcoma prognosis DOI Creative Commons
Hongsheng Gui, Shuai Wang, Bo Li

и другие.

Experimental Cell Research, Год журнала: 2025, Номер unknown, С. 114492 - 114492

Опубликована: Фев. 1, 2025

Osteosarcoma, a primary malignant bone tumor predominantly affecting children and adolescents, is characterized by aerobic glycolysis, which intricately linked to progression metastasis, yet its prognostic implications remain underexplored. This study aimed develop model utilizing glycolysis-related genes elucidate the functional role of P4HA1, key gene within this model, in osteosarcoma prognosis immune cell infiltration. We collected clinical transcriptomic data from patients UCSC Xena GEO databases. Through univariate Cox LASSO regression analyses, we identified 12 that significantly influence prognosis. These were employed construct risk score accurately predicted patient outcomes as demonstrated survival analysis ROC curves, with an AUC 0.899, 0.881, 0.878 for 1-year, 3-year, 5-year predictions, respectively. The was particularly effective across different subgroups. Immune infiltration revealed CD8+ T cells, naïve CD4+ resting dendritic activated mast cells contributed model's predictive power. also showed significant enrichment immune-related signaling pathways, indicating robust association between status glycolytic-related scores Notably, P4HA1 upregulated tissues promoted proliferation glycolysis-dependent manner, evidenced increased intracellular ATP levels, inhibited glucose absorption, elevated lactate levels P4HA1-overexpressing cells. promotion could be attenuated glycolysis inhibitor 2-DG, highlighting dependency P4HA1's action. In conclusion, developed integrating genes, particular emphasis on P4HA1. Our findings highlight interplay disease provides insights targeted therapies foundation further research into treatment.

Язык: Английский

Процитировано

0

Warburg effect and lactylation in cancer: mechanisms for chemoresistance DOI Creative Commons
Wenjie Zhang, Min Xia, Jiahui Li

и другие.

Molecular Medicine, Год журнала: 2025, Номер 31(1)

Опубликована: Апрель 22, 2025

Abstract In the clinical management of cancers, emergence chemoresistance represents a profound and imperative “pain point” that requires immediate attention. Understanding mechanisms is essential for developing effective therapeutic strategies. Importantly, existing studies have demonstrated glucose metabolic reprogramming, commonly referred to as Warburg effect or aerobic glycolysis, major contributor chemoresistance. Additionally, lactate, byproduct functions signaling molecule supports lysine lactylation modification proteins, which also plays critical role in However, it insufficient discuss glycolysis from single perspective. The intricate relationship between crucial promoting Thus, thorough elucidation underlying mediated by essential. This review provides comprehensive overview these further outlines exert synergistic effects, development creating positive feedback loop continues mediate this resistance. close link suggests application glycolysis-related drugs inhibitors cancer therapy may represent promising anticancer strategy. Furthermore, targeted lactylation, either alone combination with other treatments, offer new avenues overcoming

Язык: Английский

Процитировано

0